#小威设计机器人##一品分享#【吉他中心更新LOGO】吉他中心（Guitar Center）是美国最大的乐器零售商，由韦恩·米切尔（Wayne Mitchell）于1959年在好莱坞成立，当时是一家名为风琴中心（The Organ Center）的家庭和教堂用电风琴零售商，现已成为Vox电吉他和吉他的主要销售商。4月14日，Guitar Center 推出新LOGO，将吉他与字母分开。新的设计由 Guitar Center 的内部团队花了近半年的时间完成，最重要的一点是将「G」字母变清晰。经过消防调研，在LOGO中包含「G」字远比不包含它更受欢迎。完整的字母也使不熟悉该品牌的消费者变得更容易理解。（来源：标志情报局，侵删）
PS：小威智能——企业品牌自助设计平台，以人工智能和大数据为核心。在这里，人人都是设计师。体验人工智能LOGO设计，30秒上百套方案：https://t.cn/Aildx3RZ
PS：小威智能——企业品牌自助设计平台，以人工智能和大数据为核心。在这里，人人都是设计师。体验人工智能LOGO设计，30秒上百套方案：https://t.cn/Aildx3RZ
【美国FDA快讯】#新冠疫苗第4针终于也来了# #新冠疫苗第2剂加强针#
美国FDA于2022年3月29日批准为老年人及免疫功能受损的特定人群接种第2剂新冠疫苗加强针。
要点：
(1)年龄为50岁及以上人群在接种第1剂任一新冠疫苗加强针至少4个月后可打第2剂辉瑞或者莫德纳新冠疫苗加强针；
(2)年龄为12岁及以上的免疫功能受损人群（如器官移植术患者或其他相应情况）在接种第1剂任一新冠疫苗加强针至少4个月后可打第2剂辉瑞新冠疫苗加强针；
(3)年龄为18岁及以上的免疫功能受损人群（同上）在接种第1剂任一新冠疫苗加强针至少4个月后可打第2剂莫德纳新冠疫苗加强针。
详见：https://t.cn/A66pnMn2
Coronavirus (COVID-19) Update: FDA Authorizes Second Booster Dose of Two COVID-19 Vaccines for Older and Immunocompromised Individuals
For Immediate Release:
March 29, 2022
Today, the U.S. Food and Drug Administration authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people and certain immunocompromised individuals. The FDA previously authorized a single booster dose for certain immunocompromised individuals following completion of a three-dose primary vaccination series. This action will now make a second booster dose of these vaccines available to other populations at higher risk for severe disease, hospitalization and death. Emerging evidence suggests that a second booster dose of an mRNA COVID-19 vaccine improves protection against severe COVID-19 and is not associated with new safety concerns.
The agency amended the emergency use authorizations as follows:
》A second booster dose of the Pfizer-BioNTech COVID-19 Vaccine or Moderna COVID-19 Vaccine may be administered to individuals 50 years of age and older at least 4 months after receipt of a first booster dose of any authorized or approved COVID-19 vaccine.
》A second booster dose of the Pfizer-BioNTech COVID-19 Vaccine may be administered to individuals 12 years of age and older with certain kinds of immunocompromise at least 4 months after receipt of a first booster dose of any authorized or approved COVID-19 vaccine. These are people who have undergone solid organ transplantation, or who are living with conditions that are considered to have an equivalent level of immunocompromise.
》A second booster dose of the Moderna COVID-19 Vaccine may be administered at least 4 months after the first booster dose of any authorized or approved COVID-19 vaccine to individuals 18 years of age and older with the same certain kinds of immunocompromise.
美国FDA于2022年3月29日批准为老年人及免疫功能受损的特定人群接种第2剂新冠疫苗加强针。
要点：
(1)年龄为50岁及以上人群在接种第1剂任一新冠疫苗加强针至少4个月后可打第2剂辉瑞或者莫德纳新冠疫苗加强针；
(2)年龄为12岁及以上的免疫功能受损人群（如器官移植术患者或其他相应情况）在接种第1剂任一新冠疫苗加强针至少4个月后可打第2剂辉瑞新冠疫苗加强针；
(3)年龄为18岁及以上的免疫功能受损人群（同上）在接种第1剂任一新冠疫苗加强针至少4个月后可打第2剂莫德纳新冠疫苗加强针。
详见：https://t.cn/A66pnMn2
Coronavirus (COVID-19) Update: FDA Authorizes Second Booster Dose of Two COVID-19 Vaccines for Older and Immunocompromised Individuals
For Immediate Release:
March 29, 2022
Today, the U.S. Food and Drug Administration authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people and certain immunocompromised individuals. The FDA previously authorized a single booster dose for certain immunocompromised individuals following completion of a three-dose primary vaccination series. This action will now make a second booster dose of these vaccines available to other populations at higher risk for severe disease, hospitalization and death. Emerging evidence suggests that a second booster dose of an mRNA COVID-19 vaccine improves protection against severe COVID-19 and is not associated with new safety concerns.
The agency amended the emergency use authorizations as follows:
》A second booster dose of the Pfizer-BioNTech COVID-19 Vaccine or Moderna COVID-19 Vaccine may be administered to individuals 50 years of age and older at least 4 months after receipt of a first booster dose of any authorized or approved COVID-19 vaccine.
》A second booster dose of the Pfizer-BioNTech COVID-19 Vaccine may be administered to individuals 12 years of age and older with certain kinds of immunocompromise at least 4 months after receipt of a first booster dose of any authorized or approved COVID-19 vaccine. These are people who have undergone solid organ transplantation, or who are living with conditions that are considered to have an equivalent level of immunocompromise.
》A second booster dose of the Moderna COVID-19 Vaccine may be administered at least 4 months after the first booster dose of any authorized or approved COVID-19 vaccine to individuals 18 years of age and older with the same certain kinds of immunocompromise.
《管风琴_百度百科》管风琴（pipe organ），气鸣式键盘乐器，流传于欧洲的历史悠久的大型键盘乐器。管风琴音量洪大，气势雄伟，音色优美、庄重，并有多样化对比、能模仿管弦乐器效果，能演奏丰富的和声，被誉为“乐器之王”。管风琴是风琴的一种，由音管、音栓、键盘、轨杆机、风箱、琴https://t.cn/A66CuD0P
✋热门推荐